Electromed (ELMD) EBT Growth (3y) (2013 - 2026)
Electromed (ELMD) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 17.92% |
| 10 | Electromed | 329.52 Mn | 312.53 Mn | 14.64 Mn | 46.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.80% |
| Dec 31, 2025 | 42.78% |
| Sep 30, 2025 | 288.01% |
| Jun 30, 2025 | 85.30% |
| Mar 31, 2025 | 37.96% |
| Dec 31, 2024 | 35.54% |
| Sep 30, 2024 | 57.40% |
| Jun 30, 2024 | 56.62% |
| Mar 31, 2024 | 97.90% |
| Dec 31, 2023 | 13.98% |
| Sep 30, 2023 | -31.18% |
| Jun 30, 2023 | 5.72% |
| Mar 31, 2023 | 8.86% |
| Dec 31, 2022 | -7.22% |
| Sep 30, 2022 | -67.42% |
| Jun 30, 2022 | -31.04% |
| Mar 31, 2022 | 20.89% |
| Dec 31, 2021 | 16.09% |
| Sep 30, 2021 | 36.48% |
| Jun 30, 2021 | -20.49% |